VRTX Jul 2024 500.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:39PM EDT. Market open.
| Previous Close | 0.8100 |
| Open | 2.0000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 500.00 |
| Expire Date | 2024-07-12 |
| Day's Range | 0.8100 - 3.4200 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- GuruFocus.com
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
The transaction was executed at a price of $471.72 per share, as detailed in the SEC Filing. Following this sale, the insider now owns 30,099 shares of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biotechnology firm focused on developing and commercializing therapies for the treatment of cystic fibrosis and other severe diseases.
ZacksVertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
ZacksVertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
© 2024 Yahoo. All rights reserved.